Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2002;40:90-95
Published online before print June 10, 2002, doi: 10.1161/01.HYP.0000021747.43346.95
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/1/90    most recent
01.HYP.0000021747.43346.95v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trabold, F.
Right arrow Articles by Meneton, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trabold, F.
Right arrow Articles by Meneton, P.
Related Collections
Right arrow Autonomic, reflex, and neurohumoral control of circulation
Right arrow Coronary circulation
Right arrow Genetics of cardiovascular disease
Right arrow Genetically altered mice
Right arrow Hypertension - basic studies

(Hypertension. 2002;40:90.)
© 2002 American Heart Association, Inc.


Scientific Contributions

Cardiovascular Phenotypes of Kinin B2 Receptor– and Tissue Kallikrein–Deficient Mice

Fabien Trabold; Sandrine Pons; Albert A. Hagege; May Bloch-Faure; François Alhenc-Gelas; Jean-François Giudicelli; Christine Richer-Giudicelli; Pierre Meneton

From the Département de Pharmacologie, Faculté de Médecine Paris-Sud, INSERM 00-01 (F.T., S.P., J-F.G., C.R-G.), Le Kremlin-Bicêtre, France; Faculté de Médecine Necker-Enfants Malades, Université Paris (V A.A.H.), Paris, France; and INSERM U367 (M.B-F., F.A-G., P.M.), Paris, France.

Correspondence to Christine Richer-Giudicelli: Département de Pharmacologie, Faculté de Médecine Paris-Sud, 63 rue Gabriel Péri, 94276 Le Kremlin-Bicêtre, France, E-mail christine.giudicelli{at}kb.u-psud.fr; and Pierre Meneton, INSERM U367, 17 rue du Fer à Moulin, 75005 Paris, France, E-mail pmeneton@infobiogen.fr

To clarify the role of the kallikrein-kinin system in cardiovascular homeostasis, the systemic and regional hemodynamics of kinin B2 receptor–deficient (B2-/-) and tissue kallikrein–deficient (TK-/-) mice were compared with their wild-type (WT) littermates on a pure C57BL/6 genetic background. B2-/-, TK-/-, and WT adult mice were normotensive and displayed normal hemodynamic (left ventricular [LV] pressure, cardiac output, total peripheral resistance, dP/dtmax) and echocardiographic (septum and LV posterior wall thickness, LV diameter, LV mass, and LV fractional shortening) parameters. However, heart rate was lower in B2-/- mice compared with TK-/- and WT mice. In addition, B2-/- mice, but not TK-/- mice, exhibited lower coronary and renal blood flows and greater corresponding vascular resistances than did WT mice, indicating a tonic physiological vasodilating effect of bradykinin in these vascular beds. However, maximal coronary vasodilatation capacity, estimated after dipyridamole infusion, was similar in the 3 groups of mice. B2-/- mice were significantly more sensitive than were TK-/- mice to the vasoconstrictor effects of angiotensin II and norepinephrine. Finally, renin mRNA levels were significantly greater in B2-/- mice and smaller in TK-/- mice compared with WT mice. Taken together, these results indicate that under basal conditions, the kinin B2 receptor is not an important determinant of blood pressure in mice but is involved in the control of regional vascular tone in the coronaries and the kidneys. The phenotypic differences observed between TK-/- and B2-/- mice could be underlain by tissue kallikrein kinin–independent effect and/or kinin B1 receptor activation.


Key Words: kallikrein-kinin system • renin-angiotensin system • blood pressure • cardiac function • blood flow • mice




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. C. Isbell, S. Voros, Z. Yang, J. M. DiMaria, S. S. Berr, B. A. French, F. H. Epstein, S. P. Bishop, H. Wang, R. J. Roy, et al.
Interaction between bradykinin subtype 2 and angiotensin II type 2 receptors during post-MI left ventricular remodeling
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3372 - H3378.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. Messadi-Laribi, V. Griol-Charhbili, A. Pizard, M.-P. Vincent, D. Heudes, P. Meneton, F. Alhenc-Gelas, and C. Richer
Tissue Kallikrein Is Involved in the Cardioprotective Effect of AT1-Receptor Blockade in Acute Myocardial Ischemia
J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 210 - 216.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. Cayla, M. Todiras, R. Iliescu, V. V. Saul, V. Gross, B. Pilz, G. Chai, V. F. Merino, J. B. Pesquero, O. C. Baltatu, et al.
Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension
FASEB J, June 1, 2007; 21(8): 1689 - 1698.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Biyashev, F. Tan, Z. Chen, K. Zhang, P. A. Deddish, E. G. Erdos, and C. Hecquet
Kallikrein activates bradykinin B2 receptors in absence of kininogen
Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1244 - H1250.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
N. Picard, M. Van Abel, C. Campone, M. Seiler, M. Bloch-Faure, J. G.J. Hoenderop, J. Loffing, P. Meneton, R. J.M. Bindels, M. Paillard, et al.
Tissue Kallikrein-Deficient Mice Display a Defect in Renal Tubular Calcium Absorption
J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3602 - 3610.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. M. F. Leeb-Lundberg, F. Marceau, W. Muller-Esterl, D. J. Pettibone, and B. L. Zuraw
International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences
Pharmacol. Rev., March 1, 2005; 57(1): 27 - 77.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. H. Schmaier
The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R1 - R13.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. P. Schanstra, J. Duchene, F. Praddaude, P. Bruneval, I. Tack, J. Chevalier, J.-P. Girolami, and J.-L. Bascands
Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting Enzyme Systems: Decreased renal NO excretion and reduced glomerular tuft area in mice lacking the bradykinin B2 receptor
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1904 - H1908.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. D. Xiao, S. Fuchs, J. M. Cole, K. M. Disher, R. L. Sutliff, and K. E. Bernstein
Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting-Enzyme Systems: Role of bradykinin in angiotensin-converting enzyme knockout mice
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1969 - H1977.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Maestri, A. F. Milia, M. B. Salis, G. Graiani, C. Lagrasta, M. Monica, D. Corradi, C. Emanueli, and P. Madeddu
Cardiac Hypertrophy and Microvascular Deficit in Kinin B2 Receptor Knockout Mice
Hypertension, May 1, 2003; 41(5): 1151 - 1155.
[Abstract] [Full Text] [PDF]